GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Action(s) initiated or orders passed
GLAXO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
GlaxoSmithKline Pharmaceuticals has received an order dated 30 December 2025 from the Karnataka State GST authorities (Deputy Commissioner of Commercial Taxes, Bangalore) raising a total demand of Rs. 8,56,90,938 for FY 2021-22. The demand comprises tax of Rs. 4.85 crore, interest of Rs. 3.23 crore, and a penalty of Rs. 48.54 lakh. The dispute relates to the GST rate applied on certain products. The company has stated there is no impact on its financial operations and that it is evaluating the order and will take appropriate action in due course, which typically indicates it plans to appeal.
For shareholders, this is a routine tax dispute and not material to the company's overall financials given its scale, but the outcome of the appeal should be tracked. The stock is unlikely to see significant movement unless the demand escalates substantially.